Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations and Comprehensive Loss

v3.20.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Income Statement [Abstract]    
Revenue $ 0 $ 0
Operating expenses:    
Research and development 11,013 9,728
General and administrative 6,312 5,229
Depreciation and amortization 199 68
Total operating expenses 17,524 15,025
Loss from operations (17,524) (15,025)
Other income (expense):    
Gain from change in fair value of warrant liability 4,062 3,185
Other income (expense) 15 (40)
Interest income, net 13 4
Net loss before taxes (13,434) (11,876)
Income tax benefit 229 0
Net loss $ (13,205) $ (11,876)
Net loss per common share - basic and diluted (in dollars per share) $ (0.32) $ (0.46)
Weighted average common shares outstanding, basic and diluted (in shares) 40,721,406 25,904,170
Comprehensive loss:    
Net loss $ (13,205) $ (11,876)
Other comprehensive income (loss):    
Foreign currency translation (4) 35
Comprehensive loss $ (13,209) $ (11,841)